The Worldwide Patient-Derived Xenograft/PDX Model Industry is Expected to Reach $299 Million by 2026
April 30, 2021 06:33 ET
|
Research and Markets
Dublin, April 30, 2021 (GLOBE NEWSWIRE) -- The "Patient-Derived Xenograft/PDX Model Market by Type (Mouse, Rat), Tumor Type (Gastrointestinal, Gynecological, Hematological), Application (Preclinical...
Global High-Throughput Screening (HTS) Market Report 2021: Market Size is Projected to Reach $26.4 Billion by 2025 from $15.3 Billion in 2020
March 19, 2021 06:28 ET
|
Research and Markets
Dublin, March 19, 2021 (GLOBE NEWSWIRE) -- The "Global High-Throughput Screening (HTS) Market by Product (Instruments, Software, Service), Technology (Cell-based Assays, Label-Free), Application...
P2D Bioscience Lead ADHD Drug Demonstrates Efficacy in Preclinical Testing
April 12, 2011 08:00 ET
|
P2D Bioscience
CINCINNATI, OH and MUMBAI, INDIA--(Marketwire - Apr 12, 2011) - P2D Bioscience (P2D, Inc.), a pharmaceutical development company, today announced that its lead Attention Deficit/Hyperactivity Disorder...